$CELG Headlines What to do while the institutions sit

New Post Public Reply Private Reply Replies (0) Message Board

Feb 9, 2015 at 10:36 AM

$CELG Headlines

What to do while the institutions sit on the sideline 3:26 p.m. Feb. 5, 2015 - The Trading Deck
Celgene revenue rises on cancer-drug sales 8:04 a.m. Jan. 29, 2015 - MarketWatch.com
Major U.S. benchmarks challenge last-ditch support 11:31 a.m. Jan. 20, 2015 - Michael Ashbaugh
Major U.S. benchmarks challenge last-ditch support 11:09 a.m. Jan. 20, 2015 - Michael Ashbaugh
Some of the Nasdaq’s leading lights have begun to dim 2:02 p.m. Jan. 15, 2015 - The Trading Deck
GameStop shares rally on strong holiday sales 5:48 p.m. Jan. 13, 2015 - MarketWatch
Celgene shares gain 3.6% to top S&P 500 9:40 a.m. Jan. 13, 2015 - Sue Chang
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Updates, advisories and surprises 12:31 p.m. Jan. 12, 2015 - MarketWatch
Celgene's 2015 profit outlook is below forecasts 12:18 p.m. Jan. 12, 2015 - MarketWatch.com
Celgene's stock rises, but off highs after profit outlook 11:48 a.m. Jan. 12, 2015 - Tomi Kilgore
Celgene's stock gains 1.2% after Q4 profit view tops expectations 11:26 a.m. Jan. 12, 2015 - Tomi Kilgore
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:27 a.m. Dec. 26, 2014 - MarketWatch
Dow ekes out gain for 37th record close of 2014 2:55 p.m. Dec. 24, 2014 - Carla Mozee
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
A teachable moment: Here are my worst stock picks of 2014 10:19 a.m. Dec. 23, 2014 - Jeff Reeves
Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Liquid growth stocks tell interesting tale 3:10 p.m. Dec. 9, 2014 - The Trading Deck

No Deceleration Here: 14 Stocks With Accelerating Profits 5:29 p.m. Feb. 6, 2015 - Investors Business Daily
4 (More) Biotech Stocks to Buy 8:06 a.m. Feb. 6, 2015 - InvestorPlace.com
OncoMed Starts Dosing in Non-Small Cell Lung Cancer Study - Analyst Blog 4:20 p.m. Feb. 5, 2015 - Zacks.com
Predictable Fast Growing Healthcare Dividend Growth And Growth Stocks For Your Retirement Portfolios: Part 5 11:51 a.m. Feb. 5, 2015 - Seeking Alpha
The Idiocy Of Gilead's Undervaluation 11:17 a.m. Feb. 5, 2015 - Seeking Alpha
Violent Market Swings - Cramer's Mad Money (2/4/15) 7:20 a.m. Feb. 5, 2015 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead 8:26 p.m. Feb. 4, 2015 - TheStreet.com
Oil, Earnings, Strong U.S. Dollar Keeping Stocks in 'No Man's Land' 2:26 p.m. Feb. 4, 2015 - TheStreet.com
Celleration Acquisition Just the Start of Alliqua's M&A Strategy 1:18 p.m. Feb. 4, 2015 - GuruFocus.com
3 Stocks Dragging In The Health Care Sector 12:13 p.m. Feb. 4, 2015 - TheStreet.com
Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog 11:47 a.m. Feb. 4, 2015 - Zacks.com
Jim Cramer: Don't Bail on Biotech or Chipotle Mexican Grill 10:58 a.m. Feb. 4, 2015 - TheStreet.com
Today's Market: Stocks On The Rise, Blowout Earnings And Dividend Increases 10:44 a.m. Feb. 4, 2015 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Fiat, It's Sensation 6:00 a.m. Feb. 4, 2015 - TheStreet.com
Chicken Is A Commodity - Cramer's Lightning Round (2/3/15) 5:40 a.m. Feb. 4, 2015 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: What a Difference a Month Makes 8:19 p.m. Feb. 3, 2015 - TheStreet.com
Repros Files for Androxal in the U.S. for Hypogonadism - Analyst Blog 6:15 p.m. Feb. 3, 2015 - Zacks.com
Top Performing Funds Favor Leisure, Medical, REITs 5:22 p.m. Feb. 3, 2015 - Investors Business Daily
Eli Lilly/Boehringer Type II Diabetes Drug Gains FDA Nod - Analyst Blog 4:55 p.m. Feb. 3, 2015 - Zacks.com
Portfolio Managers Love These 5 Biotech Stocks 8:37 a.m. Feb. 3, 2015 - 247WallSt.com

Critical Alerts For Juno Therapeutics Inc, Westport Innovations, Disney, Twitter and Celgene Released By InvestorsObserver 9:31 a.m. Feb. 5, 2015 - PR Newswire - PRF
Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics 9:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
Celgene Corporation to Webcast at Upcoming Investor Conferences 8:30 a.m. Jan. 27, 2015 - BusinessWire - BZX
Celgene Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer 7:19 a.m. Jan. 23, 2015 - BusinessWire - BZX
Critical Alerts For Apple, VoxelJet, Celgene, TASER International and Finisar Released By InvestorsObserver 9:31 a.m. Jan. 22, 2015 - PR Newswire - PRF
Insider Trading Buzz for Alcoa, Southwestern Energy, Celgene, Micron, FXCM, and Twitter 8:45 a.m. Jan. 21, 2015 - PR Newswire - PRF
Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis 12:24 p.m. Jan. 16, 2015 - BusinessWire - BZX
Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis 9:10 a.m. Jan. 16, 2015 - BusinessWire - BZX
Hogging the Limelight: New Research on Netlist, Celgene, Jamba, Citigroup and Tilly's 8:40 a.m. Jan. 14, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Celgene Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Critical Alerts For Invensense, FireEye, General Electric, Twitter and Celgene Released By InvestorsObserver 9:31 a.m. Dec. 22, 2014 - PR Newswire - PRF
Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris 8:40 a.m. Dec. 17, 2014 - PR Newswire - PRF
Data Presented on REVLIMID® (lenalidomide) Compared with Investigators’ Choice in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 8:34 p.m. Dec. 8, 2014 - BusinessWire - BZX
Additional Analyses of High-Risk Patients from Phase III Study (AML-001) OF Vidaza® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at ASH 8:33 p.m. Dec. 8, 2014 - BusinessWire - BZX
REVLIMID® (Lenalidomide) Single-Agent and Combination Studies in Mantle Cell Lymphoma (MCL) Presented at ASH 8:33 p.m. Dec. 8, 2014 - BusinessWire - BZX
New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition 2:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH 1:49 p.m. Dec. 8, 2014 - BusinessWire - BZX
Age, Renal Impairment and Depth of Response Analyses of the FirstTM (MM-020/IFM 07-01)Study of Continuous REVLIMID® (lenalidomide) Plus Low-Dose dexamethasone in Newly-Diagnosed Multiple Myeloma Presented at ASH 9:58 p.m. Dec. 7, 2014 - BusinessWire - BZX
Critical Alerts For Noodles & Company, Goldcorp, YY, Celgene and LinkedIn Released By InvestorsObserver 9:31 a.m. Dec. 2, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Barco, VUE Partner to Elevate German Cinemas

Alright, cinema tech enthusiasts, gather up. Remember when going to the movies was just about the popcorn and hoping the ticket lines were short? Now we're witnessing cinema transform into an all-out tech arena, and that’s where Barco and VUE come into play. It seems these folks have decided the German film scene deserves a makeover. Yep, we're talking about pimping out...

TransPerfect Launches College Bowl Game in Puerto Rico

Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...

Navigating Legal Advice Post-Car Crash: A Crucial Guide

It's a simple blink-and-you-miss-it moment: one second you're cruising down the street, and the next you're in a fender bender. But if you think you can handle everything solo from here on out, think again. A HelloNation article featuring Pittsburgh attorney Frank Walker brings crucial clarity to when and why you might need a lawyer after a car crash. The Misleading Calm...

PKGD Group's Agave Spirits Surge 56% in 2026 Growth'

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

45% of Firms Lack AI Integration Leadership

Unclaimed Territory in the AI Era Mid-market businesses have leapt onto the AI bandwagon with wild enthusiasm, yet they're stumbling in the dark when it comes to making it work. The latest findings from Lever Talent, a talent evolution firm, spill the beans that about 45% of these outfits lack a designated maestro to lead the AI-human orchestra. Without a clear conductor,...

AI Tool circMAC Enhances MicroRNA Mapping on circRNAs

Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...

Green Builder Media's Fresh Focus on Net Zero Homes

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Texas A&M-San Antonio Opens $55M Health Hub

Building Blocks for Future Health Experts They say money talks, and down in San Antonio, it just shouted loud and clear. Texas A&M University-San Antonio sliced the ribbon on a $55 million Public Health and Education building, a step that isn’t just about bricks and mortar, but life-saving insights and hands-on training that'll ripple across South Texas. This isn’t...

Travel FOMO Trumps High Costs: Family Drives Demand

Sky-High Travel Costs? No Problem Who'd have thought folks would still be packing their bags with travel costs through the roof? Well, it seems like Americans have their priorities straight—or not, depending on how you look at it. Travel insurance provider Squaremouth reports insured trips are up 12.9% year over year, even with the average trip costing a whopping...

JiMMYBAR! Expands Military Retail Footprint Globally

Proteins and Military: A New Rollout Out of the blue, JiMMYBAR! is shaking things up by beefing up their military retail footprint with America's FIRST Creatine + Protein Bar. What's driving this charge? A leap from just promises to actually stocking shelves in 149 military locations worldwide. From home base in the good ol' U.S. of A. to as far-flung as South Korea,...